BLOOD TYPE) Methodology: Tube Agglutination BBK Set Up: Daily, As Ordered ABORH BLOOD TYPE 6.0 Ml Whole Blood (Pink) ABORH Report Available: Same Day

Total Page:16

File Type:pdf, Size:1020Kb

BLOOD TYPE) Methodology: Tube Agglutination BBK Set Up: Daily, As Ordered ABORH BLOOD TYPE 6.0 Ml Whole Blood (Pink) ABORH Report Available: Same Day LAB OE TEST REFERENCE SPECIMEN ORDER ORDER PROCEDURE RANGE REQUIREMENTS MNEMONIC NAME ABORH GROUP (BLOOD TYPE) Methodology: Tube agglutination BBK Set up: Daily, as ordered ABORH BLOOD TYPE 6.0 mL whole blood (Pink) ABORH Report available: Same day CPT Code: 86900, 86901 ACA or ACLA - See Anti-Cardiolipin Antibodies ACE - see Angiotensin-1 Converting Enzyme ACETAMINOPHEN, SERUM Methodology: Immunoassay 1 mL blood (Gn -Li (PST)) Set up: Daily, as ordered or LAB ACETAMINOPHEN Accompanies report Report available: Same day 1 mL serum (SS) ACET Minimum: 0.5 mL CPT Code: 80329 ACETYLCHOLINE RECEPTOR 1.0 mL serum (SS) BINDING ANTIBODIES (QUEST 206) Minimum: 0.5 mL ACETYLCHOLINE BINDING Methodology: RIA LAB Accompanies report RECEP Set up: Tues-Sat Allow serum to clot at room ACETYL BIND Report available: 1-2 days temperature. Serum should be separated from cells within 1 CPT Code: 83519 hour of collection. ACETYLCHOLINE RECEPTOR BLOCKING ANTIBODIES (QUEST 34459) 1.0 mL serum (SS) centrifuge ACETYLCHOLINE Methodology: RIA with 1 hr of collection LAB Accompanies report BLOCKING RECEP Set up:Mon, Wed, Fri ACETYL BLO Report available: Next day Minimum:0.5 mL CPT Code: 83519 ACETYLCHOLINE RECEPTORMODULATING ANTIBODY (QUEST 26474) 1 mL serum (SS) ACETYLCHOL LAB Methodology: RIA Accompanies report MODULATING RECEP ACETYL MOD Set up: Tue,Thur,Sun Minimum: 0.5 mL Report available: 5 days CPT Code: 83519 ACETYLCHOLINESTERASE, QUALITATIVE, GEL ELECTROPHORESIS (QUEST 185314) This test is automatically performed on all 1.5 mL Amniotic fluid, ROOM Alpha-Fetroprotein amniotic fluids with a TEMP LAB ACETYL-CHOLINESTERASE Negative MoM greater then 1.99 ACETYL Methodology: Gel Electrophoresis Minimum: 0.5 mL Set up: Tues, Thurs evening Report available: Next Day CPT Code: 82664 ACETYLSALICYLIC ACID (SALICYLATE) Therapeutic range:0-30 Methodology: Colormetric mg/dL 1 mL serum (SS) or LAB SALICYLATE Detection Limit: 3.9 mb/dL SALIC Set up: Daily Toxic: Greater then 41 1 mL blood (Gn-Li (PST)) Report available: Same day mg/dL CPT Code: 80329 ACID-FAST (TB) CULTURE - See Culture, Acid-Fast (TB) ACID-FAST (TB) SMEAR Methodology: Smear Set up: Sun-Sat 9:00AM - 3:00PM Minimum: Primary specimen LAB Reports available: Next day if clinically No acid-fast bacilli observed (sputum, exudates, hear-fixed smear,or AFBST indicated complete first morning urine) CPT Code: 87206 ACID PHOSPHATASE, PROSTATIC (PAP) (QUEST 7812) Methodology: Immunoassay 1mL serum (SS), FROZEN* LAB PROSTATIC ACID Set up: Mon-Fri pm Accompanies report ACID PHOS -PAP PHOSPHATASE Report available: Next day Minimum: 0.5 mL CPT Code: 84066 1.5 mL EDTA plasma (L) FROZEN [Collect between 7a and 10a, if drawn at any other time reference ranges do ACTH ADRENOCORTICOTROPIC not apply.] HORMONE Maintain collection tube in as ice bath (QUEST 211) before and after Methodology: Immunoassay LAB ACTH Accompanies report collection of blood. Mix well and Set up: Mon-Fri am ACTH centrifuge at 4 C, separate plasma from Report available: 2 days cells, store and ship plasma frozen in plastic vial. CPT Code: 82024 Minimum: 0.5 mL 1 ml blood (Gn -Li (PST)) or ACTH STIMULATION PANEL 1 mL serum (SS) Cortisol,Baseline: >5 ug/dL Collect Baseline specimen. Collect 30 Methodology: Chemiluminescence Cortisol, 30 Minutes: >20 minute and 1 hour specimens post LAB ACTH STIMULATION PANEL Set up: Daily ug/dL administration of 250 mg Cortrosyn ACTH STIM PANEL Report available: Same Day Cortisol,1 Hour: >20 ug/dL Do not collect, testing must be CPT Code: 80400 scheduled through SSU by Office ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) Methodology: Optical detection clotting 2.7 mL plasma (LB) assay FROZEN Set up: Daily Report available: Same day Draw blood into light blue top tube, filling PARTIAL LAB 23.2 to 27.1 seconds tube to the blue line indicted on the tube THROMBOPLASTIN TIME NOTE: Drawing blood through an indwelling PTT label. Centrifuge, remove plasma, and catheter risks heparin contamination of the freeze if not tested within 4 hours of specimen. Flush the line with saline and collection. draw 5 mL blood before Coagulation specimens are drawn CPT Code: 85610 ADAPIN-See Doxepin ADENOSINE DEAMINASE, PLEURAL FLUID 0.5 mL pleural fluid in sterile, plastic, (QUEST 17696) screw-capped vial LAB ADENOSINE DEAMINASE Methodology: Kinetic FROZEN Accompanies report ADA FLUID PLEURAL FL Set up: Mon - Fri am Report available: 1 day Minimum: 0.1 mL CPT Code: 84311 ADENOVIRUS ANTIBODY GROUP (QUEST 0382) 1 mL serum (SS) Methodology: CF LAB ADENOVIRUS ANTIBODY Set up: Mon-Fri am Accompanies report ADENOVIRUS AB SERUM Minimum: 0.5 mL Report available: 3 days CPT Code: 86603 3 mL Conjunctival swab in VCM ADENOVIRUS CULTURE transport tube, 2.5 mL nasal aspitate in (QUEST 759) sterile container, 3 mL stool in viral Methodology: Rapid Culture LAB transport media, or 3 mL throat swab in ADEOVIRUS CULTURE Set up: Daily, am Accompanies report ADENOVIRUS CULT M4 Multiuse viral transport medium, or Report available: 4 days 50 mL first-morning urine in sterile contrainer, or Bronchial lavage/wash in CPT Code: 87254 M4 transport media. AFB Culture - See Culture, Acid- Fast AFB Smear - See Acid-Fast (TB) Smear. Smear is included in AFB Culture AFP - See Alpha-Fetoprotein AIDS - See HIV ALANINE AMINOTRASFERASE (ALT) (SGPT) 1 ml blood (Gn -Li (PST)) Methodology: Kinetic or ALANINE LAB Set up: Daily Accompanies report 1 mL serum (SS) AMINOTRANSFERASE SGPT Report available: Same day Minimum: 0.5 mL CPT Code: 84460 ALBUMIN 1 ml blood (Gn -Li (PST)) Methodology: Colorimetric or Set up:Daily LAB ALBUMIN Accompanies report 1 mL serum (SS) Report available: Same day ALB Minimum: 0.5 mL CPT Code: 82040 ALBUMIN/CREATININE RATIO Methodology: Turbidometric/Colorimetric URINE ALBUMIN Set up:Daily LAB Accompanies report 10mL random urine CREATININE RATIO Report available: Same day ALB-CREA CPT Code: 82043, 82570 ALBUMIN, BODY FLUID Performed at York Hospital Methodology: Colorimetric LAB ALBUMIN BODY FLUID Set up:Daily Accompanies report 2 mL fluid, no preservative BFALB Report available: Next day CPT Code: 82042 1 mL serum (SS) ALCOHOL, ETHYL (SERUM) Minimum 0.5 mL Methodology: Enzymatic Set up: Daily LAB ALCOHOL SERUM None detected When collecting blood , the arm should Report available: Same say ALCOHOL be cleansed with a non-alcohol cleansing agent. CPT Code: 80320 ALCOHOL, ETHYL (URINE) (QUEST 13867) Detection Limit: 0.02 g/dL 20 mL urine Methodology: Immunoassay LAB URINE ALCOHOL None detected Set up: Mon-Fri U ALCOHOL Minimum: 5 mL Report available: Next day CPT Code: 80307 ALCOHOL, ETHYL, URINE BY GCMS FOR RANDOM URINE (QUEST 19938) Detection Limit: 20 mg/dL 10 mL random urine LAB ALCOHOL URINE BY GCMS Methodology: GC Accompanies report ROOM TEMPERATURE ALCOHOL UR Set up: Mon-Fri am Minimum: 0.5 mL Report available: 2 days CPT Code: 80320 ALCOHOL, ISOPROPYL, BLOOD (QUEST 7821) 5 mL blood (L) Includes acetone, if present ROOM TEMPERATURE Methodology: Chromatography Minimum: 1 mL LAB ISOPROPANOL BLOOD Detection Limit: 0.005 g/DI Accompanies report ISOPROPANOL BLD Set up: Mon - Fri pm When collecting blood, the arm should Report available: 2 days be cleansed with a non-alcohol cleansing agent. CPT Code: 84600 ALCOHOL, METHYL (METHANOL) 5 mL whole blood (L) (QUEST 4301) Methodology: Chromatography Minimum: 1 mL Detection Limit: 0.005 g/dL LAB METHANOL Accompanies report Set up : Daily METHANOL When collecting blood, the arm should Report available: Next day be cleansed with a nonalcohol cleansing agent. CPT Code: 80320 ALDOLASE (QUEST 227) 2.0 mL serum (SS), centrifuge within 1 Methodology: Enzymatic hour of collection to avoid hemolysis Set up: Mon-Fri LAB ALDOLASE Accompanies report FREEZE Report available: Next day ALDOLASE Minimum: 1 mL CPT Code: 82085 ALDOLAT- see Nifedipine ALDOSTERONE (QUEST 53532) Methodology: LC/MS/MS 1 mL serum (R) Set up: Mon-Fripm LAB ALDOSTERONE SERUM Accompanies report Report available: 3 days ALDOSTERON Minimum: 0.25 mL CPT Code: 82088 ALDOSERONE, 24 HR URINE 5 mL aliquot of 24-hr urine, collected (QUEST 13856) without preservatives and maintained at Methodology: Extraction, RIA 4 C. ALDOSTERONE 24 HR LAB Set up: Sun,Tue Accompanies report Before storing or shipping, add 1 g boric URINE ALDOSTERONE UR Report available: 4 days acid/100 mL urine and ship refrigerated. CPT Code: 82088 Minimum: 0.8 mL ALKALINE PHOSPHATASE (ALP, ALK 1 ml blood (Gn -Li (PST)) PHOS) or Methodology: PNPP 1 mL serum (SS) LAB ALKALINE PHOSPHATASE Set up: Daily Accompanies report ALP Report available: Same day Minimum: 0.5 mL CPT Code: 84075 ALKALINE PHOSPHATASE FRACTIONATION (TOTAL AND THEMOSTABLE) (QUEST 17514X) 2 mL serum (SS) ALK PHOSPHATASE Methodology: Kinetic LAB Accompanies report FRACTIONS Set up: Daily ALKPHOSFR Minimum: 2.0 mL Report available: Next day CPT Code: 84075, 84078 ALKALINE PHOSPHATASE, BONE SPECIFIC 1 mL serum (SS) (QUEST 29498) FROZEN Methodology: Immunoenzymatic Minimum: 0.3 mL LAB ALK PHOS BONE SPECIFIC Accompanies report Set up: Mon - Fri pm ALK PHOS BONE Report available: Next day Grossly hemolyzed specimens will be rejected. CPT Code: 84075 ALKALINE PHOSPHATASE ISOENZYME ELECTROPHORESIS (QUEST 231X) Report includes alkaline phosphatase 2 mL serum (SS) LAB ALK PHOS ISOENZYME Methodology: Agarose Electrophoresis Accompanies report *overnight fasting is preferred ALK ISO Set up: Mon-Fri, Sun pm Minimum: 1 mL Report available: Next day CPT Code: 84075, 84080 See Appendix A for Allergy Panel Testing available through Quest Diagnostics. Use Appendix A to determine correct panel. If correct panel cannot be determined, order
Recommended publications
  • A Case of Mistaken Identity…
    Gastroenterology & Hepatology: Open Access Case Report Open Access A case of mistaken identity… Abstract Volume 5 Issue 8 - 2016 Paragangliomas are rare tumors of the autonomic nervous system, which may origin from Marina Morais,1,2 Marinho de Almeida,1,2 virtually any part of the body containing embryonic neural crest tissue. Catarina Eloy,2,3 Renato Bessa Melo,1,2 Luís A 60year-old old female, with a history of resistant hypertension and constitutional Graça,1 J Costa Maia1 symptoms, was hospitalized for acute renal failure. In the investigation, a CT scan revealed 1General Surgery Department, Portugal a 63x54mm hepatic nodule in the caudate lobe. Intraoperatively, the tumor was closely 2University of Porto Medical School, Portugal attached to segment 1, but not depending directly on the hepatic parenchyma or any other 3Instituto de Patologia e Imunologia Molecular da Universidade adjacent structure, and it was resected. Histology reported a paraganglioma. Postoperative do Porto (IPATIMUP), Portugal period was uneventful. Correspondence: J Costa Maia, Sao Joao Medical Center, A potentially functional PG was mistaken for an incidentaloma, due to its location, General Surgery Department, Portugal, interrelated illnesses and unspecific symptoms. PG may mimic primary liver tumors and Email therefore should be a differential diagnosis for tumors in this location. Received: August 29, 2016 | Published: December 30, 2016 Background and hydrochlorothiazide), was admitted to the Internal Medicine Department due to gastroenteritis and dehydration-associated acute Paragangliomas (PG) are rare tumors of the autonomic nervous renal failure (ARF). She reported weight loss (more than 15%), system. Their origin takes part in the neural crest cells, which produce anorexia, asthenia, polydipsia, polyuria and frequent episodes of 1 neuropeptides and catecholamines.
    [Show full text]
  • Urology & Kidney Disease News
    CLEVELAND CLINI Urology & Kidney Disease News C Glickman Urological & Kidney Institute A Physician Journal of Developments in Urology and Nephrology Vol. 21 | Winter 2012 G lickman Urological & Kidney I n stitute | Urology & Kidney Disease News | 21 l. V o 2 012 In This Issue: 17 45 58 Robotic Surgery with the Post-Transrectal Ultrasound The ABCDs of Antibiotic Dosing Adjunctive Use of Fluorescent (TRUS)- Guided Prostate Biopsy in Continuous Dialysis Imaging for Prostate Cancer Infection – Importance of Quality and Outcomes Surveillance 60 36 The Potential Role of Stem Cells Determinants of Renal Function 51 in Relief of Urinary Incontinence After Partial Nephrectomy: Molecular Insights into Implications for Surgical Technique Salt-Sensitive Hypertension 72 NextGenSM Home Sperm Banking Kit clevelandclinic.org/glickman 44 56 for Men from Geographically Remote Gene Expression Profiling of Critical Care Nephrology – Testing Sites Seeking Fertility Preservation Prostate Cancer: First Step to the Old and Finding the New Services: An Exciting Development Identifying Best Candidates for Active Surveillance 78224_CCFBCH_Cover_ACG.indd 1 12/12/11 7:37 PM Urology & Kidney Resources for Physicians Resources for Patients Physician Directory Disease News View all Cleveland Clinic staff online at Medical Concierge clevelandclinic.org/staff. For complimentary assistance for out-of-state patients and families, call 800.223.2273, ext. Referring Physician Center Chairman’s Report ....................................................................4 55580, or email [email protected]. For help with service-related issues, information about our News from the Glickman Urological & Kidney Institute clinical specialists and services, details about CME oppor- Global Patient Services tunities, and more, contact the Referring Physician Center Chair Established in Urological Oncology Research ......................5 For complimentary assistance for national at [email protected], or 216.448.0900 or 888.637.0568.
    [Show full text]
  • Test Directory
    800.541.7891 509.755.8600 Test Directory Fax 509.921.7107 Billing Code Test Code [sunquest] (1,3)-BETA-D-GLUCAN (FUNGITELL) 13BGA 13BGA Synonyms Fungitell; Glucan Container Type Red top tube (plain) Store and Transport Refrigerated Specimen Type Serum Preferred Volume 2 mL Minimum Volume 0.5 mL Specimen Processing Separate serum from cells within 2 hours of collection and transfer to a standard PAML aliquot tube Room Temp Unacceptable Refrigerated 2 weeks Frozen (-20°C) 2 weeks Unacceptable Condition Hemolyzed, lipemic and icteric samples Reference Laboratory ARUP Reference Lab Test Code 2002434 CPT Codes 87449 Test Schedule Mon-Fri Turnaround Time 2-4 days Method Semi-Quantitative Colorimetry Test Includes (1,3-beta-D-glucan, pg/mL; (1,3-beta D-glucan Interpretation. Notes Reference ranges for pediatric patients (less than 18 years old) have not been established. Assay ranges were validated in adult subjects. Supply Item Number 1372 Billing Code Test Code [sunquest] 1, 5 ANHYDROGLUCITOL (GLYCOMARK) GLYMAR GLYMAR Synonyms Anhydroglucitol, 1,5 AD; GlycoMark® Container Type Serum separator tube (gold, brick, SST, or corvac) Store and Transport Refrigerated Specimen Type Serum Preferred Volume 1 mL Minimum Volume 0.2 mL Specimen Processing Allow serum specimen to clot completely at room temperature. Separate serum or plasma from cells and transfer to a standard PAML aliquot tube Room Temp 1 week Refrigerated 1 week Frozen (-20°C) 1 month Alternate Specimens Lavender (EDTA) Reference Laboratory ARUP Reference Lab Test Code 0081335 CPT Codes 84378 Test Schedule Mon-Fri Turnaround Time 2-4 days Method Quantitative Enzymatic Test Includes GlycoMark, ug/mL.
    [Show full text]
  • Biogenic Amine Reference Materials
    Biogenic Amine reference materials Epinephrine (adrenaline), Vanillylmandelic acid (VMA) and homovanillic norepinephrine (noradrenaline) and acid (HVA) are end products of catecholamine metabolism. Increased urinary excretion of VMA dopamine are a group of biogenic and HVA is a diagnostic marker for neuroblastoma, amines known as catecholamines. one of the most common solid cancers in early childhood. They are produced mainly by the chromaffin cells in the medulla of the adrenal gland. Under The biogenic amine, serotonin, is a neurotransmitter normal circumstances catecholamines cause in the central nervous system. A number of disorders general physiological changes that prepare the are associated with pathological changes in body for fight-or-flight. However, significantly serotonin concentrations. Serotonin deficiency is raised levels of catecholamines and their primary related to depression, schizophrenia and Parkinson’s metabolites ‘metanephrines’ (metanephrine, disease. Serotonin excess on the other hand is normetanephrine, and 3-methoxytyramine) are attributed to carcinoid tumours. The determination used diagnostically as markers for the presence of of serotonin or its metabolite 5-hydroxyindoleacetic a pheochromocytoma, a neuroendocrine tumor of acid (5-HIAA) is a standard diagnostic test when the adrenal medulla. carcinoid syndrome is suspected. LGC Quality - ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043 Reference materials Product code Description Pack size Epinephrines and metabolites TRC-E588585 (±)-Epinephrine
    [Show full text]
  • Endocrine Abstracts Vol 65
    Endocrine Abstracts November 2019 Volume 65 ISSN 1479-6848 (online) Society for Endocrinology BES 2019 11–13 November 2019, Brighton published by Online version available at bioscientifica www.endocrine-abstracts.org Volume 65 Endocrine Abstracts November 2019 Society for Endocrinology BES 2019 11–13 November 2019, Brighton VOLUME EDITORS The abstracts submitted were marked by the Abstract Marking panel, selected by the Programme Organising Committee. Programme Committee D Bassett (Programme Secretary) (London) Laura Matthews (Leeds) Andrew Childs (Programme Co-ordinator) (London) Carla Moran (Cambridge) Nils Krone (Programme Co-ordinator) (Sheffield) Annice Mukherjee (Salford) Helen Simpson (Programme Co-ordinator) (London) Francesca Spiga (Bristol) Davide Calebiro (Birmingham) Jeremy Tomlinson (Oxford) Ben Challis (Cambridge) Jennifer Walsh (Sheffield) Mandy Drake (Edinburgh) Abstract Marking Panel Ramzi Ajjan (Leeds) Neil Gittoes (Birmingham) John Newell-Price (Sheffield) Richard Anderson (Edinburgh) Helena Gleeson (Birmingham) Mark Nixon (Edinburgh) Ruth Andrew (Edinburgh) Philippa Hanson (London) Finbarr O’Harte (Ulster) Weibke Arlt (Birmingham) Martin Hewison (Birmingham) Adrian Park (Cambridge) Mo Aye (Hull) Claire Higham (Manchester) Simon Pearce (Newcastle) Tom Barber (Warwick) Steve Hillier (Edinburgh) Andrew Powlson (Cambridge) Duncan Bassett (London) Andy James (Newcastle) Teresa Rea (Belfast) Roger Brown (Edinburgh) Channa Jayasena (London) Martin Read (Birmingham) Paul Carroll (London) Niki Karavitaki (Oxford) Aled Rees (Cardiff)
    [Show full text]
  • Anti-Insulin Antibodies in Von Freien Und Totalen Anti-Insulin Dans Le Sérum Humain Human Serum Antikörpern in Humanserum
    Février 2019 – Modèle 014 Cisbio Bioassays Parc Marcel Boiteux – BP 84175 – 30200 Codolet / France - Tél. 33 (0)4.66.79.67.00 ANTI-INSULIN AAI ANTIBODIES Trousse pour le dosage radioimmunologique Kit for radioimmunoassay for determination Kit zur radioimmunologischen Bestimmung des anticorps anti-insuline libres et totaux of free and total anti-insulin antibodies in von freien und totalen Anti-Insulin dans le sérum humain human serum Antikörpern in Humanserum La trousse contient : Kit content : Inhalt des Kits : Traceur ≤ 52 kBq 2 x 5 mL Tracer ≤ 52 kBq 2 x 5 mL Tracer ≤ 52 kBq 2 x 5 mL Solution précipitante 1 x 100 mL Precipitating solution 1 x 100 mL Präzipitationslösung 1 x 100 mL Réactif d’extraction 1 x 10 mL Extraction reagent 1 x 10 mL Extraktionsreagenz 1 x 10 mL Tampon de neutralisation 1 x 10 mL Neutralization buffer 1 x 10 mL Neutralisationspuffer 1 x 10 mL Contrôle négatif (C1) 1 x qsp 1 mL Negative control 1 x qs 1 mL Negativkontrolle 1 x qs 1 mL Contrôle positif (C2) 1 x qsp 1 mL Positive control 1 x qs 1 mL Positivkontrolle 1 x qs 1 mL Mode d’emploi 1 Instruction for use 1 Gebrauchsinformation 1 Attention : Certains réactifs contiennent de l’azoture de sodium Warning : Some reagents contain sodium azide Achtung : Einige Reagenzien enthalten Natriumazid Kit per il dosaggio radioimmunologico degli Equipo radioinmunológica para la Δοκιμασία για τον ραδιοανοσολογικό anticorpi anti-insulina liberi e totali nel siero determinación de los anticuerpos anti- προσδιορισμό των ελεύθερων και συνολικών umano insulina libres y totales en suero humano αντισωμάτων έναντι της ινσουλίνης στον ανθρώπινο ορό .
    [Show full text]
  • Genotype - Reflex Phenotype Test Number: 3811200 Revision Date: 08/30/2015 LOINC Code: Not Specified
    Regional Medical Laboratory 4142 South Mingo Road Tulsa, OK. 74146-3632 Order Name: ALPH 1 GEN Alpha-1 Antitrypsin, Genotype - Reflex Phenotype Test Number: 3811200 Revision Date: 08/30/2015 LOINC Code: Not Specified TEST NAME METHODOLOGY LOINC CODE Alpha-1-Antitrypsin Immunoturbidimetry 1825-9 Alpha-1-Antitrypsin S Allele PCR/Fluorescence Monitoring 1829-1 Alpha-1-Antitrypsin Z Allele PCR/Fluorescence Monitoring 1831-7 Alpha-1-Antitrypsin Interpretation 1830-9 Alpha-1-Antitrypsin Phenotype Isolectric Focusing 49244-7 SPECIMEN REQUIREMENTS Specimen Specimen Volume (min) Specimen Type Specimen Container Transport Environment Preferred See Instructions EDTA Whole Blood & EDTA (lavender top) and Clot Refrigerated Serum Activator SST (Red/Gray or Tiger Top) Instructions Collect BOTH Serum separator tube AND lavender (EDTA) Allow serum to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection. Transport: 1.0 mL (0.5mL) Serum AND 3 mL(0.5mL) Whole blood Refrigerated. GENERAL INFORMATION Testing Schedule Varies Expected TAT 2-10 Days Notes Alpha-1-antitrypsin serum protein concentration determination and A1A genotyping are performed on all specimens. If two deficiency alleles (ZZ, SZ, or SS) are detected, then no further testing will be added. If the protein concentration is less than 90 mg/dL and only one or no deficiency allele is detected by A1A genotyping, then phenotyping will be added. Additional charges apply. CPT Code(s) 82103, 81332; If reflexed, add 82104 Lab Section Reference Lab Service provided by Regional Medical Laboratory - Visit us Online at: www.rmlonline.com All Rights Reserved. © 2013 - 2015 Regional Medical Laboratory 4142 South Mingo Road Tulsa, OK.
    [Show full text]
  • KPNW Specimen Requirements ***Please Hit 'Ctrl'+'F' to Open the 'Find on This Page' Funtion
    Page 1 of 368 KPNW Specimen Requirements ***Please hit 'Ctrl'+'F' to open the 'Find on this page' funtion. Panel Name Panel Description Preferred Collection/Volume: RED 10 No Gel Barrier Tubes Volume: 1.0 mL Serum Alternative Collection: GRN Li Hep or LAV EDTA Volume: 1.0 mL Plasma TAT: Report available: 5 Days Test Schedule: Saturday Morning Method: Liquid Chromatography/Tandem Mass Spectrometry Test Facility: Quest Diagnostics Nichols Inst San Juan Capistrano 33608 Ortega Highway San Juan Capistrano, CA 92690-6130 Clinical Data: 11-Deoxycortisol (Compound S) is useful in diagnosing patients with 11-beta- hydroxylase deficiency (second leading cause of congenital adrenal hyperplasia) and 11-Deoxycortisol primary (adrenal failure) or secondary (hypothalmic-pituitary ACTH deficiency) adrenal insufficiency. Patient Preparation: An early morning specimen is preferred Specimen Stability: Room Temperature: 4 days Refrigerated: 4 days Frozen: 4 weeks Ship serum frozen or refrigerated Test Code: CHANTILLY T.C.30543 TO SJC TC 30543X Processing: Centrifuge and aliquot into Referred Tests aliquot tube. Note if serum or plasma on specimen. Freeze solid. Transport: Transport frozen on ice. Preferred Collection/Volume: Preserve 24-hour urine with 25 mL of 50% Acetic Acid (preferred) or 30 mL 6N HCl or 1 gram Boric Acid/100 mL (acceptable) during collection. Refrigerate during collection. TAT: Next Day Test Schedule: Monday-Friday Night Method: Colorimetric Test Facility: Quest Diagnostics Nichols Institute 14225 Newbrook Drive Chantilly, VA 20153 17 Ketosteroids Total Pediatric 24 Hr Urine Labeling: Please specify on the request form and on the urine container the patient's age, sex, and (Includes Creatinine the total 24-hour urine volume Ratio) Specimen Stability: Room Temperature: 8 hours Refrigerated: 7 days Frozen: 30 days (-20c) Please specify on the request form and on the urine container the patient's age, sex, and the total 24-hour urine volume.
    [Show full text]
  • 1 Detection of Antibodies Directed to the N-Terminal Region of GAD Is
    Page 1 of 30 Diabetes Detection of antibodies directed to the N-terminal region of GAD is dependent on assay format and contributes to differences in the specificity of GAD autoantibody assays for type 1 diabetes Short running title: Improved specificity of autoantibodies to N-terminally truncated GAD Alistair JK Williams1, Vito Lampasona2, Michael Schlosser3, Patricia W Mueller4, David L Pittman5, William E Winter5, Beena Akolkar6, Rebecca Wyatt1, Cristina Brigatti2, Stephanie Krause7, Peter Achenbach7 and Participating Laboratories 1. School of Clinical Sciences, University of Bristol, Bristol, UK 2. Division of Genetics and Cell Biology & Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy 3. Department of Medical Biochemistry and Molecular Biology and Institute of Pathophysiology, University Medical Center of Greifswald, Karlsburg, Germany 4. Molecular Risk Assessment Laboratory, Centers for Disease Control and Prevention, Atlanta, GA, USA 5. Department of Pathology, University of Florida, Gainesville, FL, USA 6. Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA 7. Institute of Diabetes Research, Helmholtz Zentrum München, and Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Neuherberg, Germany Correspondence to – Alistair Williams Diabetes and Metabolism, School of Clinical Sciences Learning and Research Building, Southmead Hospital Bristol BS10 5NB Fax: +44 117 323 5336 Tel: +44 117 414 7900 [email protected] Word count: 2836 Figures: 4 Supplemental figures: 3 Supplemental table: 1 Supplemental appendix: 1 1 Diabetes Publish Ahead of Print, published online May 13, 2015 Diabetes Page 2 of 30 ABSTRACT Autoantibodies to glutamate decarboxylase (GADA) are sensitive markers of islet autoimmunity and type 1 diabetes.
    [Show full text]
  • Negative Urinary Fractionated Metanephrines and Elevated
    Metab y & o g lic lo S o y n n i r d Endocrinology & Metabolic c r o o m d n e E Carrillo et al., Endocrinol Metab Synd 2015, 4:1 ISSN: 2161-1017 Syndrome DOI: 10.4172/2161-1017.1000i004 Clinical Image Open Access Negative Urinary Fractionated Metanephrines and Elevated Urinary Vanillylmandelic Acid in a Patient with a Sympathetic Paravesical Paraganglioma Lisseth Fernanda Marín Carrillo1* and Edwin Antonio Wandurraga Sánchez2 1Centro Médico Carlos Ardila Lulle, Carrera 24 # 154-106, Urbanización El Bosque, Torre B Módulo 55 consultorio 806, Floridablanca, Santander, Colombia 2Deparment of Endocrinology and Molecular Oncology, Universidad Autónoma de Bucaramanga UNAB Campus El Bosque, Calle 157 # 14 – 55 Floridablanca, Santander, Colombia *Corresponding author: Lisseth Fernanda Marín Carrillo, Centro Médico Carlos Ardila Lulle, Carrera 24 # 154-106, Urbanización El Bosque. Torre B Módulo 55 consultorio 806, Floridablanca, Santander, Colombia, Tel: +57689303, +573188481025; E-mail: [email protected] Received date: Jan 06, 2015, Accepted date: Jan 07, 2015, Published date: Jan 9, 2015 Copyright: © 2015 Carrillo LFM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Clinical Image hrs). An 18 fluorodeoxiglucose PET/CT study (18 FDG PET/CT) showed an abnormal glucose uptake in the bladder with 16.9 SUVs. No distant metastases were reported. Surgical resection was performed successfully and antihypertensive medication was discontinued. The patient remains asymptomatic and normotensive (unmedicated). Results of genetic testing are pending [1-3].
    [Show full text]
  • Diagnosis of Extra-Adrenal Phaeochromocytoma After
    162 Central European Journal of Urology C A S E R E P O R T UROLOGICAL ONCOLOGY Diagnosis of extra‐adrenal phaeochromocytoma after nephrectomy 1 2 3 4 Dimitri Barski , Samer Ezziddin , Sebastian Heikaus , Hartmut P. H . Neumann 1Department of Urology, Lukas Hospital Neuss, Germany 2Department of Nuclear Medicine, Friedrich–Wilhelms–University of Bonn, Germany 3Institute of Pathology, Heinrich–Heine–University of Duesseldorf, Germany 4Department of Nephrology, Albert‐Ludwigs‐University of Freiburg, Germany Article history This case describes a 50–yr–old man who was admitted to the Urology Ward upon the suspicion of a Submitted: Feb. 2, 2014 left kidney tumor. As part of the pre–operative check–up, an ultrasound and computed tomography Accepted: March 26, 2014 of the kidneys were conducted. The results confirmed the initial diagnosis. The postoperative diagnosis was extra‐adrenal pararenal phaeochromocytoma (ePCC) with succinate dehydrogenase Correspondence Dimitri Barski complex, subunit B (SDHB) gene mutation. During the follow–up, a second tumor was detected Lukas Hospital Neuss by 3,4–dihydroxy–6–F–18–fluoro–L–phenylalanine positron emission tomography/computed 84, Preussenstr. tomography F–DOPA–PET CT that resulted in another surgery with complete resection of the tumor. 41464 Neuss The patient and his family were counseled by a genetic laboratory and remain under surveillance. Germany phone: +02131 888 2401 [email protected] Key Words: extra‐adrenal phaeochromocytoma ‹› diagnosis ‹› therapy ‹› surgery CASE DESCRIPTION chorionic gonadotropin (ßHCG), Alpha–fetoprotein (AFP), Prostate–specific antigen (PSA), Cancer anti- In February 2009, a 50–yr–old man in good gener- gen (CA19–9), and Carcinoembryonic antigen (CEA)] al health complaining of left upper abdominal pain, were normal.
    [Show full text]
  • Plasma Free Metanephrines for Diagnosis of Neuroblastoma Patients
    Clinical Biochemistry 66 (2019) 57–62 Contents lists available at ScienceDirect Clinical Biochemistry journal homepage: www.elsevier.com/locate/clinbiochem Plasma free metanephrines for diagnosis of neuroblastoma patients T Sebastiano Barcoa,1, Iedan Verlyb,c,d,1, Maria Valeria Corriase, Stefania Sorrentinof, Massimo Contef, Gino Tripodia, Godelieve Tytgatb,c, André van Kuilenburgd, Maria van der Hamg, ⁎ Monique de Sain-van der Veldeng, Alberto Garaventaf, Giuliana Cangemia, a Central Laboratory of Analyses, IRCCS Istituto Giannina Gaslini, Genoa, Italy b Department of Pediatric Oncology, Amsterdam UMC, Amsterdam, the Netherlands c Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands d Laboratory of Genetic Metabolic Disorders, Amsterdam UMC, Amsterdam, the Netherlands e Laboratory of experimental therapies in oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy f Department of Pediatric oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy g Department of Genetics, Section Metabolic Diagnostics, WKZ, Utrecht, the Netherlands ARTICLE INFO ABSTRACT Keywords: Introduction: A substantial number of patients with neuroblastoma (NB) have increased excretion of catecho- Plasma free metanephrines lamines and metanephrines. Here, we have investigated the diagnostic role of plasma free metanephrines (PFM), Neuroblastoma metanephrine (MN), normetanephrine (NMN) and 3-methoxytyramine (3MT) for NB, the most common extra- Liquid chromatography-tandem mass cranial solid tumour in children. spectrometry Methods: PFM were quantified by using a commercial IVD-CE LC-MS/MS method on a TSQ Quantiva coupled to Diagnosis an Ultimate 3000. The method was further validated on 103 samples from pediatric subjects (54 patients with histologically confirmed NB and 49 age and sex matched controls). Correlations between PFM concentrations with clinical factors were tested.
    [Show full text]